| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 8063381
[patent_doc_number] => 20110245331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'INHIBITORS OF EPOXIDE HYDROLASES FOR THE TREATMENT OF HYPERTENSION'
[patent_app_type] => utility
[patent_app_number] => 13/113028
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11546
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245331.pdf
[firstpage_image] =>[orig_patent_app_number] => 13113028
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/113028 | INHIBITORS OF EPOXIDE HYDROLASES FOR THE TREATMENT OF HYPERTENSION | May 19, 2011 | Abandoned |
Array
(
[id] => 7696124
[patent_doc_number] => 20110230466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it'
[patent_app_type] => utility
[patent_app_number] => 13/068551
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1768
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230466.pdf
[firstpage_image] =>[orig_patent_app_number] => 13068551
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/068551 | Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it | May 12, 2011 | Abandoned |
Array
(
[id] => 7574130
[patent_doc_number] => 20110269786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME IN DIABETIC PATIENTS USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 13/098261
[patent_app_country] => US
[patent_app_date] => 2011-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19575
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269786.pdf
[firstpage_image] =>[orig_patent_app_number] => 13098261
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/098261 | TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME IN DIABETIC PATIENTS USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES | Apr 28, 2011 | Abandoned |
Array
(
[id] => 6048666
[patent_doc_number] => 20110207742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE'
[patent_app_type] => utility
[patent_app_number] => 13/096477
[patent_app_country] => US
[patent_app_date] => 2011-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10362
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207742.pdf
[firstpage_image] =>[orig_patent_app_number] => 13096477
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/096477 | METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE | Apr 27, 2011 | Abandoned |
Array
(
[id] => 6064566
[patent_doc_number] => 20110201688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'N,N\'-DI-P-BROMOPHENYL GUANIDINE TREATMENT FOR STROKE AT DELAYED TIMEPOINTS'
[patent_app_type] => utility
[patent_app_number] => 13/090828
[patent_app_country] => US
[patent_app_date] => 2011-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5464
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201688.pdf
[firstpage_image] =>[orig_patent_app_number] => 13090828
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/090828 | N,N'-DI-P-BROMOPHENYL GUANIDINE TREATMENT FOR STROKE AT DELAYED TIMEPOINTS | Apr 19, 2011 | Abandoned |
Array
(
[id] => 8056177
[patent_doc_number] => 20120077829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'PARENTERAL SOLUTIONS CONTAINING METOLAZONE'
[patent_app_type] => utility
[patent_app_number] => 13/076297
[patent_app_country] => US
[patent_app_date] => 2011-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2367
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077829.pdf
[firstpage_image] =>[orig_patent_app_number] => 13076297
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/076297 | PARENTERAL SOLUTIONS CONTAINING METOLAZONE | Mar 29, 2011 | Abandoned |
Array
(
[id] => 8697843
[patent_doc_number] => 20130059851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 13/583056
[patent_app_country] => US
[patent_app_date] => 2011-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 26258
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583056
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/583056 | Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy | Mar 8, 2011 | Abandoned |
Array
(
[id] => 6048665
[patent_doc_number] => 20110207741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death'
[patent_app_type] => utility
[patent_app_number] => 13/032629
[patent_app_country] => US
[patent_app_date] => 2011-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19045
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207741.pdf
[firstpage_image] =>[orig_patent_app_number] => 13032629
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/032629 | Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death | Feb 21, 2011 | Abandoned |
Array
(
[id] => 6214388
[patent_doc_number] => 20110136876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'Altering Pharmacokinetics of Pirfenidone Therapy'
[patent_app_type] => utility
[patent_app_number] => 13/028827
[patent_app_country] => US
[patent_app_date] => 2011-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8861
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136876.pdf
[firstpage_image] =>[orig_patent_app_number] => 13028827
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/028827 | Altering Pharmacokinetics of Pirfenidone Therapy | Feb 15, 2011 | Abandoned |
Array
(
[id] => 8685108
[patent_doc_number] => 20130053392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'CARBONIC ANHYDRASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/578654
[patent_app_country] => US
[patent_app_date] => 2011-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14132
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578654
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/578654 | CARBONIC ANHYDRASE INHIBITORS | Feb 13, 2011 | Abandoned |
Array
(
[id] => 6213877
[patent_doc_number] => 20110136739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'Use of S1P Receptor Agonists in Heart Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/023423
[patent_app_country] => US
[patent_app_date] => 2011-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4820
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136739.pdf
[firstpage_image] =>[orig_patent_app_number] => 13023423
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/023423 | Use of S1P Receptor Agonists in Heart Diseases | Feb 7, 2011 | Abandoned |
Array
(
[id] => 6039503
[patent_doc_number] => 20110092552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids'
[patent_app_type] => utility
[patent_app_number] => 12/977111
[patent_app_country] => US
[patent_app_date] => 2010-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6409
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092552.pdf
[firstpage_image] =>[orig_patent_app_number] => 12977111
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/977111 | Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids | Dec 22, 2010 | Abandoned |
Array
(
[id] => 8685066
[patent_doc_number] => 20130053350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/515522
[patent_app_country] => US
[patent_app_date] => 2010-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27494
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515522
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/515522 | PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | Dec 14, 2010 | Abandoned |
Array
(
[id] => 6118620
[patent_doc_number] => 20110076293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/961367
[patent_app_country] => US
[patent_app_date] => 2010-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12581
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20110076293.pdf
[firstpage_image] =>[orig_patent_app_number] => 12961367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/961367 | TRIPTOLIDE DERIVATIVES FOR MODULATION OF APOPTOSIS AND IMMUNOSUPPRESSION | Dec 5, 2010 | Abandoned |
Array
(
[id] => 5937743
[patent_doc_number] => 20110213027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY'
[patent_app_type] => utility
[patent_app_number] => 12/951494
[patent_app_country] => US
[patent_app_date] => 2010-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13189
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20110213027.pdf
[firstpage_image] =>[orig_patent_app_number] => 12951494
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/951494 | USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY | Nov 21, 2010 | Abandoned |
Array
(
[id] => 6016978
[patent_doc_number] => 20110224293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY'
[patent_app_type] => utility
[patent_app_number] => 12/951471
[patent_app_country] => US
[patent_app_date] => 2010-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13195
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224293.pdf
[firstpage_image] =>[orig_patent_app_number] => 12951471
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/951471 | USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY | Nov 21, 2010 | Abandoned |
Array
(
[id] => 8394247
[patent_doc_number] => 20120232087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES'
[patent_app_type] => utility
[patent_app_number] => 13/509857
[patent_app_country] => US
[patent_app_date] => 2010-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13904
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509857
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/509857 | METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES | Nov 16, 2010 | Abandoned |
Array
(
[id] => 7501739
[patent_doc_number] => 20110263601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'METHODS OF TREATING ULCERATIVE COLITIS'
[patent_app_type] => utility
[patent_app_number] => 12/911011
[patent_app_country] => US
[patent_app_date] => 2010-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 32108
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263601.pdf
[firstpage_image] =>[orig_patent_app_number] => 12911011
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/911011 | METHODS OF TREATING ULCERATIVE COLITIS | Oct 24, 2010 | Abandoned |
Array
(
[id] => 5993506
[patent_doc_number] => 20110015159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'METHODS OF INHIBITING VASCULAR PERMEABILITY AND APOPTOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/894783
[patent_app_country] => US
[patent_app_date] => 2010-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8716
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015159.pdf
[firstpage_image] =>[orig_patent_app_number] => 12894783
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/894783 | Methods of inhibiting vascular permeability and apoptosis | Sep 29, 2010 | Issued |
Array
(
[id] => 6033189
[patent_doc_number] => 20110082114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/895073
[patent_app_country] => US
[patent_app_date] => 2010-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16800
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20110082114.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895073
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895073 | Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors | Sep 29, 2010 | Abandoned |